ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for monitor ブラジル証券取引所、NASDAQ、NYSE、AMEX、LSEなどの主要取引所からの複数のリアルタイム株価を監視します。

GOSS Gossamer Bio Inc

0.60
0.021 (3.63%)
2024年6月1日 - 終了
15分遅延
名称 銘柄コード 市場 種別
Gossamer Bio Inc GOSS NASDAQ 普通株式
  前日比 前日比 % 現在値 時刻
0.021 3.63% 0.60 13:00:05
始値 安値 高値 終値 前日終値
0.5719 0.5719 0.6081 0.59 0.579
この銘柄の詳細情報 »

最新ニュース

日付 時間 ソース タイトル
2024/5/1505:01BWGossamer Bio to Provide Updated Seralutinib TORREY..
2024/5/1105:30BWGossamer Bio Announces Inducement Grant Under Nasdaq Listing..
2024/5/0805:02EDGAR2Form 8-K - Current report
2024/5/0805:01EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/5/0805:01BWGossamer Bio Announces First Quarter 2024 Financial Results..
2024/5/0620:31EDGAR2Form 8-K - Current report
2024/5/0620:30BWGossamer Bio and Chiesi Group Announce Transformative Global..
2024/5/0321:02BWGossamer Bio Announces Publication of TORREY Phase 2 Results..
2024/3/1220:31BWGossamer Bio Announces Appointment of Steven D. Nathan,..
2024/3/0521:37EDGAR2Form S-8 - Securities to be offered to employees in employee..
2024/3/0521:32EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
2024/3/0521:31EDGAR2Form 8-K - Current report
2024/3/0521:31BWGossamer Bio Announces Fourth Quarter and Full-Year 2023..
2024/3/0506:02EDGAR2Form 8-K - Current report
2024/1/0906:01BWGossamer Bio Announces Inducement Grant Under Nasdaq Listing..
2024/1/0507:11EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/1/0507:04EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/1/0507:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/12/1406:01BWGossamer Bio to Host Webcast to Discuss Latest Seralutinib..
2023/12/0607:12EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/12/0607:09EDGAR2Form 3 - Initial statement of beneficial ownership of..
2023/12/0606:01BWGossamer Bio Announces Inducement Grant Under Nasdaq Listing..
2023/12/0521:01BWGossamer Bio Appoints Bob Smith as Chief Commercial Officer
2023/11/3006:01EDGAR2Form 8-K - Current report
2023/11/2921:01BWGossamer Bio Announces Appointment of John Quisel, J.D.,..
2023/11/2806:01EDGAR2Form 8-K - Current report
2023/11/2309:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/11/2309:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/11/2309:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/11/1806:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/11/1508:24EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/11/0921:31EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/11/0921:31EDGAR2Form 8-K - Current report
2023/11/0921:31BWGossamer Bio Announces Third Quarter 2023 Financial Results..
2023/10/2105:01EDGAR2Form 8-K - Current report
2023/10/0405:08BWGossamer Bio Announces Addition of Rainer Zimmermann, MD, as..
2023/9/0806:00EDGAR2Form 8-K - Current report
2023/9/0720:44BWGossamer Bio to Present Results of TORREY FRI Sub-Study at..
2023/8/2913:15EDGAR2Form EFFECT - Notice of Effectiveness
2023/8/2905:29EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
2023/8/2205:01EDGAR2Form DEL AM - Delaying amendment
2023/8/1821:41EDGAR2Form S-3 - Registration statement under Securities Act of..
2023/8/1821:38EDGAR2Form RW - Registration Withdrawal Request
2023/8/1805:01EDGAR2Form S-3ASR - Automatic shelf registration statement of..
2023/8/0905:03EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/8/0905:01EDGAR2Form 8-K - Current report
2023/8/0905:01BWGossamer Bio Announces Second Quarter 2023 Financial Results..
2023/7/2904:46EDGAR2Form SC 13D - General statement of acquisition of beneficial..
2023/7/2705:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/7/2505:16BWGossamer Bio to Hold Conference Call with PAH Experts to..

最近閲覧した銘柄

Delayed Upgrade Clock